Related Experiment Videos
[Cryocoagulation in retinopathy of prematurity]
Klinische Monatsblatter Fur Augenheilkunde
|November 1, 1987
Summary
Transconjunctival cryocoagulation effectively treated retinopathy of prematurity in stage 2 infants, even when considered unnecessary. However, this treatment was less effective for stage 3 retinopathy of prematurity.
Area of Science:
- Ophthalmology
- Neonatology
- Pediatric Medicine
Context:
- Retinopathy of prematurity (ROP) is a significant cause of vision loss in premature infants.
- Current treatment guidelines for ROP vary, particularly for early stages.
Purpose:
- To evaluate the efficacy of transconjunctival cryocoagulation in different stages of retinopathy of prematurity in premature infants.
Summary:
- Transconjunctival cryocoagulation was applied to 38 eyes of 21 premature infants with stage 2-4 ROP.
- In stage 2, cryocoagulation was performed for hemorrhages, dilated retinal vessels, or rubeosis iridis.
- The procedure was highly effective in stage 2 ROP, even when deemed potentially superfluous, but showed limited effectiveness in stage 3.
Impact:
- Findings suggest transconjunctival cryocoagulation may be a valuable intervention for early-stage ROP.
- Results challenge the notion that stage 2 ROP treatment is always superfluous.
- Further research may refine treatment protocols for ROP based on disease stage.